|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.04 USD | -1.92% |
|
+2.53% | +9.68% |
| Mar. 28 | Pulmatrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | Pulmatrix, Inc. Approves Termination of Margaret Wasilewski as Chief Medical Officer | CI |
Pulmatrix, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 6.07 million compared to USD 5.17 million a year ago. Net loss was USD 18.84 million compared to USD 20.17 million a year ago.
Basic loss per share from continuing operations was USD 5.46 compared to USD 8.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.68% | 7.45M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
PULMATRIX, INC. 
